A new statewide research initiative is underway to evaluate an experimental blood test that could change the future of cancer screening.

“Our system, which is called OneTouch-PAT, combines advanced imaging, automation and artificial intelligence — all while ...

The National Cancer Institute-funded study, which will include up to 24,000 people, will screen for a variety of cancers. More news is on dogs detecting Parkinson's; progress in the Influenza Vaccines ...

Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that screens for several different cancers called multi-cancer detection (MCD) tests ...

For years, it has been one of the most tantalising ideas in medicine: one day, a simple blood test will detect nascent ...

UNSW Sydney scientists are working to develop Australia's first commercialised lipid-based blood test for breast cancer detection powered by ...

Prostate cancer is the most common cancer in Australia, with about 26,000 men diagnosed per year. The majority (more than 85% ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that patient enrollment has begun in the National Cancer Institute (NCI)’s Vanguard Study to evaluate emerging ...

A national pilot study designed to determine if blood tests can help detect cancers earlier is open for enrollment.Results of ...

Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that screens for several different cancers called multi-cancer detection (MCD) tests ...

Two brothers from Wigan are both celebrating the end of successful cancer treatment after being diagnosed with prostate cancer within a month of each other.